Beal Benjamin R, Wallace Mark S
Division of Pain Medicine, Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA.
Division of Pain Medicine, Department of Anesthesiology, University of California, San Diego, San Diego, CA, USA.
Med Clin North Am. 2016 Jan;100(1):65-79. doi: 10.1016/j.mcna.2015.08.006. Epub 2015 Oct 27.
Patients with chronic pain can be challenging to manage and historically providers have relied on opiates to treat pain. Recent studies have brought into question the safety and efficacy of chronic opiate therapy in the noncancer population. There is a vast amount of literature to support the use of nonsteroidal anti-inflammatory medications, antidepressants, anticonvulsants, topical agents, cannabinoids, and botulinum toxin either in conjunction with or in lieu of opioids. Intrathecal drug delivery systems can deliver some of these medications directly to their primary site of action while minimizing the side effects seen with systemic administration.
慢性疼痛患者的管理颇具挑战性,从历史上看,医疗服务提供者一直依赖阿片类药物来治疗疼痛。最近的研究对非癌症人群中慢性阿片类药物治疗的安全性和有效性提出了质疑。有大量文献支持使用非甾体抗炎药、抗抑郁药、抗惊厥药、局部用药、大麻素和肉毒杆菌毒素,这些药物可与阿片类药物联合使用或替代阿片类药物。鞘内药物输送系统可以将其中一些药物直接输送到其主要作用部位,同时将全身给药时出现的副作用降至最低。